Italia markets closed

BMY Jan 2026 62.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,60000,0000 (0,00%)
In data: 01:01PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,6000
Aperto2,1000
Denaro1,4000
Lettera1,5600
Prezzo d'esercizio62,50
Scadenza2026-01-16
Min-Max giorno1,5900 - 2,1000
Contratto - Min-MaxN/D
Volume21
Open Interest316
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri